Meeting Details
The 41st Annual General Meeting (AGM) of Arvaya Healthcare Limited was held on Monday, 21 September 2026 through Video Conferencing in compliance with relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India.
The meeting commenced at 3:02 PM and concluded at 3:31 PM.
Attendees and Proceedings
CS Guinea Agrawal welcomed shareholders and introduced Board Members, Senior Management Officials, representatives of Statutory Auditors, Secretarial Auditors, and Scrutinizers attending the meeting.
Key procedural announcements:
- Notice dated 12 August 2026 convening the AGM and Auditors' Report for financial year ended 31 March 2026 were taken as read
- Remote e-voting commenced on Friday, 18 September 2026 from 9:00 AM to Sunday, 20 September 2026 until 5:00 PM
- Mr. Chinmay Mohan Lele, Practicing Company Secretary, was appointed as Scrutinizer to scrutinize the remote e-voting process and e-voting at the AGM
- Quorum was confirmed present
Chairman's Address
Mr. Kaushal Shah, Chairman and Managing Director (DIN: 02175130), addressed shareholders with key operational highlights and strategic direction for FY 2025-26:
Strategic Re-branding: The Company officially transitioned to Arvaya Healthcare Limited, reflecting its broader vision and expanded focus in the healthcare sector.
Business Expansion & Corporate Updates:
- Incorporated Arvaya Insurance Broking Private Limited as a Wholly-Owned Subsidiary on 17th September 2026 to diversify business operations and enhance overall stakeholder value
- Currently in process of acquiring Sushoda Institute of Gastroenterology Private Limited to expand footprint and service capabilities within healthcare sector
- Undertaking a Rights Issue of equity shares to support growth initiatives and strengthen balance sheet capacity
Governance & Financial Discipline: Strong emphasis on maintaining sound corporate governance, regulatory compliance, internal controls, and financial discipline.
Long-Term Outlook: Reaffirmed commitment to building sustainable healthcare business and driving long-term stakeholder value.
The chairman mentioned that points and reservations in Secretarial Audit Report were addressed by management and expressed gratitude to shareholders, business partners, medical professionals, and employees.
Business Transacted
The following items of business from the Notice dated 12th August 2026 were transacted:
Ordinary Business:
1. To receive, consider and adopt the Audited Standalone Financial Statements for financial year ended 31 March 2026, and reports of Board of Directors and Auditors thereon (Ordinary Resolution)
2. To receive, consider and adopt the Audited Consolidated Financial Statements for financial year ended 31 March 2026, and reports of Auditors thereon (Ordinary Resolution)
3. To consider appointment of Mr. Kaushal Uttam Shah (DIN: 02175130) as Managing Director, who retires by rotation and offers himself for re-appointment (Ordinary Resolution)
Special Business:
4. Approval for Material Related Party Transaction(s) under Section 188 of Companies Act, 2013 and Regulation 23 of SEBI Listing Regulations (Ordinary Resolution)
5. To consider and approve Material Related Party Transaction for acquisition and assignment of Copyright and Intellectual Property portfolio of DEFIB Institute of Health Solutions LLP, out of Rights Issue proceeds (Ordinary Resolution)
Voting and Conclusion
CS Guinea Agrawal announced that consolidated e-voting results (remote e-voting and e-voting at AGM) along with consolidated scrutinizer's report would be informed to Stock Exchanges and made available on company website and NSDL website.
Mr. Abhiram Ranganath, Chief Financial Officer, thanked members for continued support and attendance. The e-voting facility remained open for 15 minutes after which the AGM concluded at 3:31 PM.